Data‐derived safety factors for the evaluation of food additives and environmental contaminants

References

• Abernethy , D. R. , Gutkowska , J. and Winterbottom , L. J. 1990 . Effects of amlodipine, a long acting dihydropyridine calcium antagonist in ageing hypertension: pharmacodynamics in relation to disposition . Clinical Pharmacology and Therapeutics , 48 : 76 – 86 .
   PubMed Web of Science ®Google Scholar
• Bachmann , K. 1989 . Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species . Journal of Applied Toxicology , 9 : 331 – 338 .
   PubMed Web of Science ®Google Scholar
• Bernard , A. M. , Lauwerys , R. R. , Noel , A. , Vandeleene , B. and Lambert , A. 1989 . Urine protein 1: a sex‐dependent marker of tubular or glomerular dysfunction . Clinical Chemistry , 35 : 2141 – 2142 .
   PubMed Web of Science ®Google Scholar
• Bichet , N. , Cahard , D. , Fabre , G. , Remandet , B. , Gouy , D. and Cano , J.‐P. 1990 . Toxicological studies on a benzofuran derivative. III Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture . Toxicology and Applied Pharmacology , 106 : 509 – 517 .
   PubMed Web of Science ®Google Scholar
• Birge , R. B. , Bartolone , J. B. , Emeigh Hart , S. G. , Nishanian , E. V. , Tyson , C. A. , Khairallah , E. A. and Cohen , S. D. 1990 . Acetaminophen hepatotoxicity: correspondence of selective protein arylation in human and mouse liver in vitro, in culture and in vivo . Toxicology and Applied Pharmacology , 105 : 472 – 482 .
   PubMed Web of Science ®Google Scholar
• Blychert , E. , Edgar , B. , Elmfeldt , D. and Hednor , T. 1991 . A population study of the pharmacokinetics of felodipine . British Journal of Clinical Pharmacology , 31 : 15 – 24 .
   PubMed Web of Science ®Google Scholar
• Borghoff , S. J. , Miller , A. B. , Bowen , J. P. and Swenberg , J. A. 1991 . Characteristics of chemical binding to α2u‐globulin in vitro—evaluating structure‐activity relationships . Toxicology and Applied Pharmacology , 107 : 228 – 238 .
   PubMed Web of Science ®Google Scholar
• Calabrese , E. J. 1985 . Uncertainty factors and interindividual variation . Regulatory Toxicology and Pharmacology , 5 : 190 – 196 .
   PubMed Web of Science ®Google Scholar
• Calabrese , E. J. , Moore , G. S. and McCarthy , M. S. 1983 . The effect of ascorbic acid on copperinduced oxidative changes in the erythrocytes of rats, sheep and normal humans . Regulatory Toxicology and Pharmacology , 3 : 179 – 183 .
   PubMedGoogle Scholar
• Calabrese , E. J. , Moore , G. S. and McCarthy , M. S. 1983 . The effect of ascorbic acid on nitriteinduced methemoglobin formation in sheep, rats and normal human erythrocytes . Regulatory Toxicology and Pharmacology , 3 : 184 – 188 .
   PubMedGoogle Scholar
• Calabrese , E. J. , Beck , B. D. and Chappell , W. R. 1992 . Does the animal to human uncertainty factor incorporate interspecies differences in surface area? . Regulatory Toxicology and Pharmacology , 15 : 172 – 179 .
   PubMed Web of Science ®Google Scholar
• Day , R. O. , Graham , G. G. , Bieri , D. , Brown , M. , Cairns , D. , Harris , G. , Hounsell , J. , Platt–Hepworth , S. , Reeve , R. , Sambrook , P. N. and Smith , J. 1989 . Concentration‐response relationships for salicylate‐induced ototoxicity in normal volunteers . British Journal of Clinical Pharmacology , 28 : 695 – 702 .
   PubMed Web of Science ®Google Scholar
• Flamm , G. W. and Lehman–McKeeman , L. D. 1991 . The human relevance of the renal tumorinducing potential of d‐limonene in male rats: implications for risk assessment . Regulatory Toxicology and Pharmacology , 13 : 70 – 86 .
   PubMed Web of Science ®Google Scholar
• Garattini , S. 1986 . Toxic effects of chemicals: difficulties in extrapolating data from animals to man . CRC Critical Reviews in Toxicology , 16 : 1 – 29 .
   Google Scholar
• Gearhart , J. M. , Jepson , G. W. , Clewell , H. J. , Andersen , M. E. and Conolly , R. B. 1990 . Physiologically based pharmaco‐kinetic and pharmaco‐dynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate . Toxicology and Applied Pharmacology , 106 : 295 – 310 .
   PubMed Web of Science ®Google Scholar
• Gerlowski , L. E. and Jain , R. K. 1983 . Physiologically based pharmacokinetic modelling: principles and applications . Journal of Pharmaceutical Sciences , 72 : 1103 – 1127 .
   PubMed Web of Science ®Google Scholar
• Gibaldi , M. and Perrier , D. 1982 . Pharmacokinetics , 2nd edn , 221 – 269 . New York : Marcel, Dekker Inc. . revised and updated
   Google Scholar
• Grahnen , A. , Wennerlund , P. , Dahlstrom , B. and Eckernas , S‐A. 1991 . Inter‐ and intraindividual variability in the concentration‐effect (sedation) relationship of flunitrazepam . British Journal of Clinical Pharmacology , 31 : 89 – 92 .
   PubMed Web of Science ®Google Scholar
• Green , T. and Odum , J. 1985 . Structure/activity studies of the nephrotoxic and mutagenic action of cysteine conjugates of chloro and fluoroalkenes . Chemical‐Biological Interactions , 54 : 15 – 31 .
   PubMed Web of Science ®Google Scholar
• Green , T. , Odum , J. , Nash , J. A. and Foster , J. R. 1990 . Perchloroethylene‐induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans . Toxicology and Applied Pharmacology , 103 : 77 – 89 .
   PubMed Web of Science ®Google Scholar
• Greenblatt , D. J. , Ehrenberg , B. L. , Gunderman , J. , Locniskar , A. , Scavone , J. M. , Harmatz , J. S. and Shader , R. I. 1989 . Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam and placebo . Clinical Pharmacology and Therapeutics , 45 : 356 – 365 .
   PubMed Web of Science ®Google Scholar
• Harries , G. C. , Boobis , A. R. , Collier , N. and Davies , D. S. 1986 . Interindividual differences in the activation of two hepatic carcinogens to mutagens in human liver . Human Toxicology , 5 : 21 – 26 .
   PubMedGoogle Scholar
• Hattis , D. , Erdrich , L. and Ballew , M. 1987 . Human variability in susceptibility to toxic chemicals—a preliminary analysis of pharmacokinetic data from normal volunteers . Risk Analysis , 7 : 415 – 426 .
   PubMed Web of Science ®Google Scholar
• Holford , N. H. G. and Sheiner , L. B. 1981 . Understanding the dose‐effect relationship: clinical application of pharmacokinetic‐pharmacodynamic models . Clinical Pharmacokinetics , 6 : 429 – 453 .
   PubMed Web of Science ®Google Scholar
• Hutt , A. J. , Caldwell , J. and Smith , R. L. 1986 . The metabolism of aspirin in man: a population study . Xenobiotica , 16 : 239 – 249 .
   PubMed Web of Science ®Google Scholar
• ILSI . Meeting of the ILSI‐Europe task force on the scientific evaluation of the safety factor for calculation of the ADI . November 29–30 1990 , Brussels. 1991 and 13–14 June 1991. (Unpublished discussion.)
   Google Scholar
• Inturrisi , C. E. , Portenoy , R. K. , Max , M. B. , Colburn , W. A. and Foley , K. M. 1990 . Pharmacokinetic‐pharmacodynamic relationships of methadone infusions in patients with cancer pain . Clinical Pharmacology and Therapeutics , 47 : 565 – 577 .
   PubMed Web of Science ®Google Scholar
• Kissel , J. C. and Robarge , G. M. 1988 . Assessing the elimination of 2,3,7,8‐TCDD from humans with a physiologically based pharmacokinetic model . Chemosphere , 17 : 2017 – 2027 .
   Web of Science ®Google Scholar
• Kitteringham , N. R. , Lambert , C. , Maggs , J. L. , Colbert , J. and Park , B. K. 1988 . A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes . British Journal of Clinical Pharmacology , 26 : 13 – 21 .
   PubMed Web of Science ®Google Scholar
• Koopmans , R. , Dingemanse , J. , Danhof , M. , Horsten , G. P. M. and Van Boxtel , C. J. 1988 . Pharmacokinetic‐pharmacodynamic modelling of midazolam effects on the human central nervous system . Clinical Pharmacology and Therapeutics , 44 : 14 – 22 .
   PubMed Web of Science ®Google Scholar
• Lu , F. C. 1988 . Acceptable daily intake: inception, evolution and application . Regulatory Toxicology and Pharmacology , 8 : 45 – 60 .
   PubMed Web of Science ®Google Scholar
• Munro , A. M. 1990 . Interspecies comparisons in toxicology: the utility and futility of plasma concentrations of the test compound . Regulatory Toxicology and Pharmacology , 12 : 137 – 160 .
   PubMed Web of Science ®Google Scholar
• Noe , D. A. and Kumor , K. M. 1991 . A pharmacokinetic‐pharmacodynamic model of heart rate during cocaine administration to humans . Clinical Pharmacology and Therapeutics , 49 : 426 – 432 .
   PubMed Web of Science ®Google Scholar
• Poiger , H. 1988 . “ Toxicokinetics of 2,3,7,8‐TCDD in man: an update ” . In Paper presented at Dioxin ‘88 Umea, , Sweden 1988
   Google Scholar
• Razak , T. A. , McNeil , J. J. , Sewell , R. B. , Prummer , O. H. , Smallwood , R. A. , Conway , E. L. and Louis , W. T. 1990 . The effect of hepatic cirrhosis on the pharmacokinetics and blood pressure response to nicardipine . Clinical Pharmacology and Therapeutics , 47 : 463 – 469 .
   PubMed Web of Science ®Google Scholar
• Renwick , A. G. 1985 . The disposition of saccharin in animals and man—a review . Food and Chemical Toxicology , 23 : 429 – 435 .
   PubMed Web of Science ®Google Scholar
• Renwick , A. G. 1991 . Safety factors and establishment of acceptable daily intakes . Food Additives and Contaminants , 8 : 135 – 150 .
   PubMed Web of Science ®Google Scholar
• Renwick , A. G. 1993 . “ Toxicokinetics. ” . In Handbook of General and Applied Toxicology , Edited by: Ballantyre , B. and Marrs , T. C. London : Macmillan Press Ltd .
   Google Scholar
• Renwick , A. G. 1993 . A data‐derived safety (uncertainty) factor for the intense sweetener saccharin . Food Additives and Contaminants , 10 : 337 – 350 .
   PubMed Web of Science ®Google Scholar
• Renwick , A. G. and Williams , R. T. 1972 . The fate of cyclamate in man and other species . Biochemical Journal , 129 : 869 – 879 .
   PubMed Web of Science ®Google Scholar
• Renwick , A. G. , Robertson , D. R. C. , MacKlin , B. , Challenor , V. , Waller , D. G. and George , C. F. 1988 . The pharmacokinetics of oral nifedipine—a population study . British Journal of Clinical Pharmacology , 25 : 701 – 708 .
   PubMed Web of Science ®Google Scholar
• Ritchie , J. C. , Crothers , M. J. , Shah , R. R. , Idle , J. R. and Smith , R. L. 1986 . The metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole‐induced agranulocytosis . Xenobiotica , 16 : 503 – 509 .
   PubMed Web of Science ®Google Scholar
• Roberts , A. and Renwick , A. G. 1989 . The pharmacokinetics and tissue concentrations of cyclohexylamine in rats and mice . Toxicology and Applied Pharmacology , 98 : 230 – 242 .
   PubMed Web of Science ®Google Scholar
• Robertson , D. R. C. , Waller , D. G. , Renwick , A. G. and George , C. F. 1988 . Age‐related changes in the pharmacokinetics and pharmacodynamics of nifedipine . British Journal of Clinical Pharmacology , 25 : 297 – 305 .
   PubMed Web of Science ®Google Scholar
• Rubery , E. D. , Barlow , S. M. and Steadman , J. H. 1990 . Criteria for setting quantitative estimates of acceptable intakes of chemicals in food in the UK . Food Additives and Contaminants , 7 : 287 – 302 .
   PubMed Web of Science ®Google Scholar
• Ruelius , H. W. 1987 . Extrapolation from animals to man: predictions, pitfalls and perspectives . Xenobiotica , 17 : 255 – 256 .
   PubMed Web of Science ®Google Scholar
• Scheuplein , R. J. , Shoaf , S. E. and Brown , R. N. 1990 . Role of pharmacokinetics in safety evaluation and regulatory decisions . Annual Reviews in Pharmacology and Toxicology , 30 : 197 – 218 .
   PubMed Web of Science ®Google Scholar
• Sheiner , L. B. , Stanski , D. R. , Vozeh , S. , Miller , R. D. and Ham , J. 1979 . Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to d‐tubocurarine . Clinical Pharmacology and Therapeutics , 25 : 358 – 371 .
   PubMed Web of Science ®Google Scholar
• Strong , H. A. , Oates , J. , Sembi , J. , Renwick , A. G. and George , C. F. 1984 . Role of the gut flora in the reduction of sulphinpyrazone in humans . Journal of Pharmacology and Experimental Therapeutics , 230 : 726 – 732 .
   PubMed Web of Science ®Google Scholar
• Sweatman , T. W. and Renwick , A. G. 1980 . The tissue distribution and pharmacokinetics of saccharin in the rat . Toxicology and Applied Pharmacology , 55 : 18 – 31 .
   PubMed Web of Science ®Google Scholar
• Tokuma , Y. , Sekiguchi , M. , Niwa , T. and Noguchi , H. 1988 . Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs . Xenobiotica , 18 : 21 – 28 .
   PubMed Web of Science ®Google Scholar
• Truhaut , R. 1991 . The concept of the acceptable daily intake: an historical review . Food Additives and Contaminants , 8 : 151 – 162 .
   PubMed Web of Science ®Google Scholar
• Vainio , H. , Hietanen , E. and Belvedere , G. 1984 . “ Pharmacokinetics and metabolism of styrene ” . In Progress in Drug Metabolism , Edited by: Bridges , J. W. and Chasseaud , L. F. Vol. 8 , 203 – 209 . London : Taylor & Francis .
   Google Scholar
• Vettorazzi , G. 1987 . Advances in the safety evaluation of food additives. A conceptual and historical overview of the Acceptable Daily Intake (ADI) and Acceptable Daily Intake ‘not specified’ . Food Additives and Contaminants , 4 : 331 – 356 .
   PubMedGoogle Scholar
• Walker , C. H. 1978 . Species differences in microsomal monooxygenase activity and their relationship to biological half‐life . Drug Metabolism Reviews , 7 : 295 – 323 .
   PubMed Web of Science ®Google Scholar
• WHO . 1987 . “ Principles for the safety assessment of food additives and contaminants in food ” . Environmental Health Criteria No. 70 Geneva : World Health Organization .
   Google Scholar
• Wilhelm , M. , Jager , D. E. and Ohnesorge , F. K. 1990 . Aluminium toxicokinetics . Pharmacology and Toxicology , 66 : 4 – 9 .
   PubMedGoogle Scholar
• Würtzen , G. 1993 . Scientific evaluation of the safety factor for the acceptable daily intake (ADI). Case study: butylated hydroxyanisole (BHA) . Food Additives and Contaminants , 10 : 307 – 314 .
   PubMedGoogle Scholar
• Zhou , H‐H. , Silberstein , D. J. , Koshakji , R. D. and Wood , A. J. J. 1989 . Interindividual differences in β‐receptor density contribute to variability in response to β‐adrenoceptor antagonists . Clinical Pharmacology and Therapeutics , 45 : 587 – 592 .
   PubMed Web of Science ®Google Scholar